Mounjaro [Tirzepatide]

Glucagon-like peptide-1 (GLP-1) receptor agonists- 30 day supply

GLP-1 and GIP receptor agonist- 30 day supply

What is Mounjaro: 
– Zepbound, generic name Tirzepatide
– FDA-approved GLP-1 and GIP receptor agonist- for chronic weight management
– weekly subcutaneous injection
How does Mounjaro work?:
– suppress appetite
– control blood sugar levels, increase insulin release
– slows gastric emptying, keeping you fuller for longer

Common side effects:

Nausea

vomiting

Diarrhea

Constipation

Fatigue

Expected results:

– coupled with lifestyle modifications- patients lose an average of 22% of their initial body weight
– expect to lose between 5-10 lbs per month, this does vary with each individual. 

$75.00 a month subscription includes
– Intial telehealth consultation
– Monthly check-in with your medical doctor
– Prior authorization specialist (Insurance support)
– Access to our partner GLP-1 pharmacy 
– DOES NOT include the cost of medication – on average with health insurance coverage, you may pay $25/month for the medication.